Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.97
- Piotroski Score 5.00
- Grade Neutral
- Symbol (AMED)
- Company Amedisys, Inc.
- Price $96.07
- Changes Percentage (0.03%)
- Change $0.03
- Day Low $96.00
- Day High $96.31
- Year High $98.95
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 10/22/2024
- Fiscal Year End N/A
- Average Stock Price Target $162.50
- High Stock Price Target $190.00
- Low Stock Price Target $85.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.64
- Trailing P/E Ratio -143.36
- Forward P/E Ratio -143.36
- P/E Growth -143.36
- Net Income $-9,747,000
Income Statement
Quarterly
Annual
Latest News of AMED
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Broadcom Inc. (AVGO) Named a Core Stock by Wells Fargo for Long-Term Growth Potential in IT Sector
A list of 30 AI stocks investors should not miss includes Broadcom Inc. (NASDAQ:AVGO). The AI data centers market is growing, with Equinix forming a joint venture to raise over $15 billion for expandi...
By Yahoo! Finance | 11 hours ago -
What schools have never hosted 'College GameDay'? Cal will be site of show for the first time Saturday
This weekend, "College GameDay" will be in Berkeley, California for the first ACC home game of the Golden Bears, Cal, against No. 8 Miami. Hosting the show signifies validation and relevance for a foo...
By USA Today | 15 hours ago -
Cal football in national spotlight as Berkeley gets ready to host "College GameDay"
UC Berkeley will host "College GameDay" ahead of their first ACC home matchup against Miami. The campus is abuzz with excitement as fans and locals anticipate the event, highlighting the Bears' newfou...
By CBS News | 18 hours ago
